Saturday 26 September 2015

Pathway Genomics' direct-to-consumer cancer diagnostic earns FDA warning letter - FierceMedicalDevices (press release) (registration)


Ledger Gazette

Pathway Genomics' direct-to-consumer cancer diagnostic earns FDA warning letter
FierceMedicalDevices (press release) (registration)
After a consumer draws blood using a Pathway Genomics testing kit with the assistance of a phlebotomist, it is shipped backed to the company laboratory for analysis, and results (positive or negative) are available within two to three weeks. Pathway ...
Pathway Genomics responds to FDA's concerns on liquid biopsy testMedCity News

all 32 news articles »


from phlebotomist - Google News http://bit.ly/1NTrbpk

No comments:

Post a Comment